Mobile Diagnostics Without Compromise

The Challenges are Global

Clinicians need critical diagnostics earlier to empower the best, actionable care pathways.

The Value is Real

Empowered clinicians give millions the opportunity of timely treatment and improved patient outcomes.

Our Goal

Is to bring trusted diagnostics to the point of initial patient interaction, to expand access of quality healthcare to new settings, no matter where that patient interaction occurs

Nanomix Goals


Internal Link

Schedule Your Demo at AACC 2022 of the Nanōmix eLab® system.

Critical Host Response Diagnostics in Minutes. Hand-held, Multiplex Immunoassay from a Single Sample.

Internal Link

Nanōmix Initiates New Clinical Study for the eLab® S1 Panel

Study incorporates the use of the Nanōmix eLab® S1 Panel within the Emergency Department of Hospital Clinico San Carlos in Madrid, Spain

Internal Link

Nanōmix Receives IVDR Certification for the eLab® Analyzer

IVDR certification enables Nanōmix to market its eLab® analyzer in the European Union under the newly established regulatory guidelines

Internal Link

Nanōmix Announces Granted CE Mark for eLab® S1 Assay Panel for Whole Blood Samples

We are very pleased to report CE mark designation in Europe for our S1 assay panel using a whole blood sample type

Internal Link

Nanōmix Announces Upgrade to OTCQB® Venture Market

Upgrading to the OTCQB is a timely and important milestone for Nanōmix, as we continue to commercialize our Nanōmix eLab® system, a mobile point-of-care diagnostic testing platform.

External Link

Nanōmix Announces Three new Customer and Distributor Congress locations and dates.

ECCMID in Portugal

Apr 23 - 26, 2022

AACC in Chicago

Jul 26 - 28, 2022

Medica in Dusseldorf

Nov 14 - 17, 2022